Thomas D. Nolin, PharmD ’99, PhD ’03, recently presented to the National Kidney Foundation (NKF) – American Society of Nephrology (ASN) Task Force to Reassess the Inclusion of Race in Diagnosing Kidney Diseases. Since September 2020, the Task Force has been hosting meetings of stakeholders across the country and examining every aspect of the inclusion of race in calculations that estimate adult kidney function with a goal of seeking a solution that is safe; equitable; will not disadvantage any patient by race, sex, or age; and will promote accurate and consistent GFR estimation for all patients throughout the United States. Nolin initially presented ‘Implications of Excluding Race from eGFR Equations on Drug Selection, Dosing, Safety and Efficacy’, and was subsequently invited for a follow up presentation titled ‘FDA Guidance on PK in Patients with Impaired Kidney Function: Impact on Use of eGFR’.
Nolin is Associate Professor in the Department of Pharmacy and Therapeutics and holds secondary appointments in the Department of Medicine Renal-Electrolyte Division and in the Clinical and Translational Science Institute.
